EUVIMEDEUVIMED entdecken
Open Access

Ruxolitinib-based senomorphic therapy mitigates cardiomyocyte senescence in septic cardiomyopathy by inhibiting the JAK2/STAT3 signaling pathway

Boshen Yang, Taixi Li, Zhixiang Wang, Yuankang Zhu, Kaifan Niu, Sien Hu, Zhiqi Lin, Xinjie Zheng, Xian Jin, Chengxing Shen

International Journal of Biological Sciences · 2024 · 20 (11) · 4314-4340

DOI: 10.7150/ijbs.96489 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2024. Verfasst von Boshen Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Janus Kinase 2, STAT3 Transcription Factor, Cellular Senescence, Signal Transduction. Die Arbeit wurde bisher 58-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Janus Kinase 2STAT3 Transcription FactorCellular SenescenceSignal TransductionMyocytes, CardiacCardiomyopathiesNitrilesPyrimidinesPyrazolesAnimalsMiceRatsMaleMice, Inbred C57BLSepsisRats, Sprague-DawleyLipopolysaccharidesDisease Models, Animal

Stichwörter der Autor:innen

Cellular senescencemitochondrial dysfunctionoxidative stress.senomorphic therapyseptic cardiomyopathy

Substanzen

ruxolitinibJanus Kinase 2STAT3 Transcription FactorNitrilesPyrimidinesPyrazolesLipopolysaccharides

Autor:innen und Institutionen

  • Department of Cardiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Institute for Developmental and Regenerative Cardiovascular Medicine, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Department of Surgery, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang, China.
  • Department of Respiratory Medicine, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, China.

Zitieren

APA

Yang, B., Li, T., Wang, Z., Zhu, Y., Niu, K., Hu, S., Lin, Z., Zheng, X., Jin, X., & Shen, C. (2024). Ruxolitinib-based senomorphic therapy mitigates cardiomyocyte senescence in septic cardiomyopathy by inhibiting the JAK2/STAT3 signaling pathway. International Journal of Biological Sciences, 20(11), 4314-4340. https://doi.org/10.7150/ijbs.96489

Vancouver

Yang B, Li T, Wang Z, Zhu Y, Niu K, Hu S, et al. Ruxolitinib-based senomorphic therapy mitigates cardiomyocyte senescence in septic cardiomyopathy by inhibiting the JAK2/STAT3 signaling pathway. International Journal of Biological Sciences. 2024;20(11):4314-4340. doi:10.7150/ijbs.96489

BibTeX
@article{Yang2024,
  author = {Yang, Boshen and Li, Taixi and Wang, Zhixiang and Zhu, Yuankang and Niu, Kaifan and Hu, Sien and Lin, Zhiqi and Zheng, Xinjie and Jin, Xian and Shen, Chengxing},
  title = {Ruxolitinib-based senomorphic therapy mitigates cardiomyocyte senescence in septic cardiomyopathy by inhibiting the JAK2/STAT3 signaling pathway},
  journal = {International Journal of Biological Sciences},
  year = {2024},
  volume = {20},
  number = {11},
  pages = {4314--4340},
  doi = {10.7150/ijbs.96489}
}
Kostenlos starten →